首页> 外文期刊>The American Journal of Human Genetics >Exome sequencing and cis-regulatory mapping identify mutations in MAK, a gene encoding a regulator of ciliary length, as a cause of retinitis pigmentosa.
【24h】

Exome sequencing and cis-regulatory mapping identify mutations in MAK, a gene encoding a regulator of ciliary length, as a cause of retinitis pigmentosa.

机译:外显子组测序和顺式调节作图可鉴定出MAK突变,该基因编码睫状体长度调节剂,是色素性视网膜炎的病因。

获取原文
获取原文并翻译 | 示例
           

摘要

A fundamental challenge in analyzing exome-sequence data is distinguishing pathogenic mutations from background polymorphisms. To address this problem in the context of a genetically heterogeneous disease, retinitis pigmentosa (RP), we devised a candidate-gene prioritization strategy called cis-regulatory mapping that utilizes ChIP-seq data for the photoreceptor transcription factor CRX to rank candidate genes. Exome sequencing combined with this approach identified a homozygous nonsense mutation in male germ cell-associated kinase (MAK) in the single affected member of a consanguineous Turkish family with RP. MAK encodes a cilium-associated mitogen-activated protein kinase whose function is conserved from the ciliated alga, Chlamydomonas reinhardtii, to humans. Mutations in MAK orthologs in mice and other model organisms result in abnormally long cilia and, in mice, rapid photoreceptor degeneration. Subsequent sequence analyses of additional individuals with RP identified five probands with missense mutations in MAK. Two of these mutations alter amino acids that are conserved in all known kinases, and an in vitro kinase assay indicates that these mutations result in a loss of kinase activity. Thus, kinase activity appears to be critical for MAK function in humans. This study highlights a previously underappreciated role for CRX as a direct transcriptional regulator of ciliary genes in photoreceptors. In addition, it demonstrates the effectiveness of CRX-based cis-regulatory mapping in prioritizing candidate genes from exome data and suggests that this strategy should be generally applicable to a range of retinal diseases.
机译:分析外显子序列数据的一个基本挑战是将致病突变与背景多态性区分开。为了在遗传异质性疾病色素性视网膜炎(RP)中解决此问题,我们设计了一种候选基因优先排序策略,称为顺式调控作图,该策略利用ChIP-seq数据获取感光受体转录因子CRX来对候选基因进行排名。外显子组测序与该方法相结合,在土耳其近亲伴RP家族的单个受影响成员中鉴定出男性生殖细胞相关激酶(MAK)的纯合性无义突变。 MAK编码一种与纤毛相关的丝裂原激活的蛋白激酶,其功能从纤毛藻类莱茵衣藻对人保守。小鼠和其他模型生物中MAK直系同源基因的突变导致异常长的纤毛,并且在小鼠中导致快速的感光细胞变性。随后对具有RP的其他个体进行的序列分析确定了5个MAK中具有错义突变的先证者。这些突变中的两个改变了所有已知激酶中保守的氨基酸,并且体外激酶测定表明这些突变导致激酶活性的丧失。因此,激酶活性对于人类的MAK功能似乎至关重要。这项研究突显了CRX作为光感受器中睫状基因的直接转录调节因子所起的作用。此外,它证明了基于CRX的顺式调控作图法在确定外显子组数据中候选基因的优先次序方面的有效性,并表明该策略通常应适用于一系列视网膜疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号